Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
CNS Drugs|October 9, 2008
Pharmacological treatment of schizophrenia and co-occurring substance use disordersDavid A Smelson, Lisa Dixon, Thomas Craig, et al.
Psychiatric Services (Washington, D.C.)|March 1, 2008
Voucher-based incentives for naltrexone treatment attendance in schizophrenia and alcohol use disordersLuba Leontieva, Jacqueline A Dimmock, Paul W Gately, et al.
Drug and Alcohol Dependence|February 19, 2002
Medical service use and financial charges among opioid users at a public hospitalCarmen L Masson, James L Sorensen, Steven L Batki, et al.
Journal of Clinical Psychopharmacology|February 21, 2013
Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trialZsuzsa Szombathyne Meszaros, Ynesse Abdul-Malak, Jacqueline A Dimmock, et al.
American Journal of Preventive Medicine|October 28, 2017
Mobile Technology for Treatment Augmentation in Veteran Smokers With Posttraumatic Stress DisorderEllen Herbst, David Pennington, Eric Kuhn, et al.
The American Journal of Drug and Alcohol Abuse|July 11, 2009
Patient and provider attitudes towards monitored naltrexone treatment of alcohol dependence in schizophreniaLuba Leontieva, Jacqueline Dimmock, Michelle Cavallerano, et al.
Pageof 6